Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles.

J Clin Med · 2021 · PMC8745251 · PMID 35011746

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Patients receiving 2.5 mg/d EDP-305 ( n = 53) showed decreased HDL-C, increased apoB concentrations and a strong trend towards increased LDL-C compared to placebo ( n = 24), while plasma triglyceride levels were not affected [ 141 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.